PLEASANTON, Calif.—The Cooper Companies, Inc. (NYSE:COO) announced financial results for the fiscal first quarter ended Jan. 31, 2015. For the period, overall revenue rose 10 percent to $445.2 million. CooperVision (CVI) revenues increased 13 percent to $369.3 million while CooperSurgical (CSI) revenues were down 4 percent to $75.8 million.

Sales of CooperVision in the Americas, which represented 43 percent of CVI revenues, increased 13 percent to $158.5 million. Sales in the EMEA region, which account for 40 percent of CVI revenues in the quarter, climbed 25 percent to $147.6 million.

CooperVision’s multifocal business grew by 26 percent in the first quarter with sales of $42 million while sales of single-use spheres increased by 22 percent to reach sales of $84.2 million. CVI’s largest segment, torics, rose 7 percent to $108.5 million.

Commenting on the results, Robert S. Weiss, Cooper's president and CEO, said, "We've started fiscal 2015 with a strong quarter. In addition to solid operational performance, our integration of Sauflon is going very well along with our U.S. launch of clariti. Although currency continues to create headwinds, we're raising our EPS guidance and remain very enthusiastic about our prospects for the remainder of the year, and into the future."